Xencor Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xencor Inc. on January 24, 2014, covering events occurring on January 17, 2014. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Atul Saran resigned from the Board of Directors, effective January 23, 2014. Mr. Saran was previously affiliated with MedImmune Ventures, Inc., but is no longer employed by that entity or its affiliates as of January 17, 2014.
- Committee Appointment: On January 23, 2014, the Board appointed Robert F. Baltera, Jr., an existing director, to the Audit Committee to fill the vacancy created by Mr. Saran's resignation.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the disclosure of the director's departure and subsequent appointment.
Key Facts for Investor Verification
- Confirm the effective date of Atul Saran's resignation (January 23, 2014).
- Verify the appointment of Robert F. Baltera, Jr. to the Audit Committee.
- Note that this filing contains no financial results or operational updates.